US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510

2022年07月01日 13:46:13 来自: (0)参与

SINGAPORE -- (BUSINESS WIRE) --

Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea, announced that the U.S. Food and Drug Administration (FDA) has approved the Phase 1/2a clinical trial of its first-in-class anti-PAUF monoclonal antibody, PBP1510 (INN: Ulenistamab), for the treatment of pancreatic cancer.

The clinical trial will be conducted on patients with advanced/metastatic pancreatic cancer in the Massachusetts General Hospital and the Ronald Reagan UCLA Medical Center by Principal Investigators (PI) comprised of leading authorities at Harvard Medical School and UCLA School of Medicine. The study aims to identify an optimal dose of PBP1510 in combination with gemcitabine through Phase 1 study and continue on Phase 2a to investigate clinical efficacy.

Pancreatic cancer is a highly aggressive malignancy which contributes to high morbidity and mortality with an overall survival rate in the U.S. of around 11%1) at five years. Currently, the only curative options are surgical resection in combination with adjuvant chemotherapy. However, only 10 to 15%2) of patients are candidates as the diagnosis occurs in advanced or metastatic stages that are surgically inoperable. Limited efficacy of treatment modalities and rapid progression of pancreatic cancer can be partly explained by Pancreatic Adenocarcinoma Up-regulated Factor (PAUF) found in majority of pancreatic cancer patients. PAUF plays an important role in disease progression, but no targeted molecular therapy against PAUF currently exists. Prestige BioPharma’s anti-PAUF antibody PBP1510 is envisioned to provide significant benefit to all patients affected by PAUF-positive pancreatic cancer.

The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Korean MFDS granted Orphan Drug Designation (ODD) to PBP1510 in 2020. ODD is granted to investigational drugs intended for the safe and effective treatment of rare diseases with an unmet medical need that affect few individuals but cause great suffering. This designation provides certain benefits and incentives including clinical protocol assistance, differentiated evaluation procedures for health technology assessments in certain countries, and if approved, marketing exclusivity in the EU for 10 years, in the U.S. for 7 years.

PBP1510 is also expected to be eligible for FDA’s accelerated approval program if certain conditions are met. This program allows for earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpoint. The company believes that PBP1510 will be able to apply for the accelerated approval program with the validated surrogate endpoint from its Phase 2 study.

Lisa S. Park, CEO of Prestige BioPharma, commented: “We are very pleased to initiate the Phase 1/2a clinical trial of PBP1510 in the world-class medical institutions in the US,” and “the company will accelerate the Phase 1/2a study of PBP1510 to demonstrate the solid evidence to provide better treatment for pancreatic cancer, an extremely difficult to treat indication with a poor response to the currently available treatments”.

1) American Cancer Society 2022, Survival Rates for Pancreatic Cancer, accessed 27 June 2022, <https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html>

2) Srustidhar D. and Surinder K. B. (2015). Pancreatic Cancer Metastasis: Are we being Pre-EMTed?. Current Pharmaceutical Design, Volume 21, Issue 10, 1249 - 1255

View source version on businesswire.com: https://www.businesswire.com/news/home/20220627005290/en/

CONTACT:

Media Inquiries:
Global Communication Team
Prestige Biopharma Ltd.
www.prestigebiopharma.com
Tel: +65-6924-6535
info@prestigebio.com

相关新闻
凤凰网友:解脱的诠释
评论:笑容是馈赠别人的见面礼,眼泪是洗涤自我的沐浴露。

猫扑网友:忘了爱° Toro
评论:木纳这事,如果干的好,叫深沉

淘宝网友:Paranoid. 偏执
评论:酒是穿肠毒药,色是刮骨钢刀,气是拦路猛虎,钱是卑贱之源

天猫网友:Alexandr 嫁衣°
评论:世界上没有绝对幸福圆满的婚姻,幸福只是来自于无限的容忍与互相尊重。

天涯网友:Cold-blooded 凉薄
评论:世界上最最废话的就是那句写在烟盒上面的“吸烟有害健康”。

本网网友:︶別致微笑ゞ
评论:既来之则安之,有福不享是傻子。

腾讯网友:颠覆 wounded
评论:小时候认为流血了就是很严重的事,不管疼不疼,先哭了再说.

搜狐网友:Chafferer  迷心
评论:好的爱情,战得胜时间,抵得住流年,经得起离别,受得住想念。

百度网友:memory’青春
评论:人生四项基本原则:懂得选择,学会放弃,耐得住寂寞,经得起诱惑。

网易网友:有你灬我很幸福
评论:人生就是这样:不是你混日子;就是日子把自己混了

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin